Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Phase 3 study of belrestotug plus dostarlimab compared with placebo plus pembrolizumab in previously untreated PD L1 high NSCLC Ended

2023-504753-12-00 Lung Cancer, Non-Small Cell 5 2024-10-01
A Phase 2 Trial of Combination Therapies with Adagrasib in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation Ended

2023-503714-77-00 Advanced Non-Small Cell Lung Cancer 4 2024-10-01
POST-SURGICAL LIQUID BIOPSY - GUIDED TREATMENT OF STAGE III AND HIGH-RISK STAGE II COLON CANCER PATIENTS - THE PEGASUS STUDY Ended

2024-517704-10-00 Colon cancer 4 2024-09-30
Ph2 Study of MK-3475A in Hematologic Malignances in Participants with Relapsed or Refractory Classical Hodgkin Lymphoma or Relapsed or Refra… Ended

2024-510969-42-00 Relapsed or Refractory Classical Hodgkin’s Lymphoma (rr 4 2024-09-30
DART (19-14434) Durvalumab (MEDI4736) After chemoRadioTherapy (DART) for NSCLC patients – a phase II translational and biomarker study inves… Ended

2022-502640-12-01 Non-small cell lung cancer (NSCLC) 9 2024-09-27
The role of sonoporation-enhanced treatment in patients with inoperable pancreatic cancer Ended

2024-512176-35-00 Pancreatic cancer 4 2024-09-27
RElapse from Mrd Negativity As iNdication for Treatment Ended

2023-510215-18-00 Multiple myeloma 10 2024-09-26
A Phase 1/2 Study of MK-2870 plus EV plus Pembrolizumab in la/mUC Ended

2023-506387-14-00 Advanced Urothelial Carcinoma 7 2024-09-24
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer Ended

2024-511038-11-00 advanced prostate cancer 4 2024-09-24
A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Ra… Ended

2022-502269-13-00 Glioma 4 2024-09-24
ELVN-002 combined with trastuzumab +/- chemotherapy in HER2 + Solid Tumors Ended

2023-509716-29-00 Solid Tumors, Colorectal Cancer and Breast Cancer 9 2024-09-23
AMG 193 in Combination with Other Therapies in Subjects with Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous… Ended

2024-511195-33-00 Gastrointestinal tract, biliary tract, or pancreatic ca 3 2024-09-23
A PHASE 1/2 STUDY EXPLORING THE SAFETY AND ACTIVITY OF TRIFLURIDINE/TIPIRACIL IN COMBINATION WITH CAPECITABINE AND BEVACIZUMAB IN METASTATIC… Ended

2024-513271-41-00 colorectal metastatic cancer 4 2024-09-16
An open-label randomized trial of zanidatamab for advanced HER2positive biliary tract cancer Ended

2023-508219-21-00 BTC - Biliary Tract Cancer 5 2024-09-12
First line treatment with VeNEtoclaX and ibruTinib induction followed by obinutuzumab intenSificaTion Exclusively in CLL/SLL Patients not in… Ended

2022-502808-72-00 Chronic Lymphocytic Leukemia 4 2024-09-11
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Capsules Compared to Intravenously (IV) Infused Rituximab Plus IV Infu… Ended

2024-510965-41-00 Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymph 5 2024-09-03
Study Title: Single cell characterization of persistent cells upon treatment with durvalumab (MEDI4736) with or without Tremelimumab in MSS … Ended

2023-509619-10-00 MSS and MSI colorectal and endometrial tumors 4 2024-08-29
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Patients with previously treated KRAS G12C-positive… Ended

2024-510908-37-00 KRAS G12C-Positive Advanced or Metastatic Non-Small Cel 5 2024-08-28
A Phase 1b, Randomized, Open-Label Trial to Evaluate Safety, Engraftment, and Initial Signs of Clinical Activity of MB097 in Combination wit… Ended

2023-507377-17-00 Advanced Melanoma 1 2024-08-28
A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer (PolyDamas) Ended

2022-501452-29-00 Metastatic Non-small Cell Lung Cancer 9 2024-08-28
Safety and preliminary efficacy of BNT314 in cancer patients with malignant solid tumors Ended

2023-506053-38-00 Advanced or metastatic malignant solid tumors 1 2024-08-27
A phase 2, Multicenter Study of TILs Treatment in Advanced Tumors with Alterations in the SWI/SNF Complex: the TILTS Study Ended

2023-504632-17-00 Advanced solid tumors 4 2024-08-14
A multicenter, open-label, randomized, phase 2 study of venetoclax and azacitidine plus cusatuzumab versus venetoclax and azacitidine alone … Ended

2024-510991-19-00 Acute myeloid leukemia 4 2024-08-14
STUDY AGORA-1 / ALFA 2100: Phase 2 on the combinaison of Gemtuzumab Ozogamicin witk gilteritinib in adult patients with acute myeloid leukem… Ended

2023-504176-25-00 Acute Myeloid Leukemia 9 2024-08-08